New data in high-risk MDS, emerging menin inhibitors in AML, and evolving care needs in rare bleeding disorders set the stage for major ASH 2025 discussions.
Shayla Bergmann, MD
Advertisement
Shayla Bergmann, MD, is a clinical professor in pediatric hematology at the Medical University of South Carolina.
Articles by Shayla Bergmann, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
2
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
Medicaid Expansion Associated With Lower Mortality in NSCLC
5
